SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-017034
Filing Date
2024-04-29
Accepted
2024-04-29 17:00:25
Documents
4
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 389766
2 formpre_001.jpg GRAPHIC 4937
3 proxy_001.jpg GRAPHIC 322796
4 proxy_002.jpg GRAPHIC 162080
  Complete submission text file 0001493152-24-017034.txt   1065877
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40789 | Film No.: 24892278
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)